Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000950170-25-038113

Options or other derivatives

  • General Counsel and Secretary acquired 750,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Samuel George A. III · General Counsel and Secretary

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-10 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +750,000 750,000 D
Loading xslF345X05/ownership.xml…